DNA-cleaving enzymes trigger a repair process that can now be harnessed to correct mutations in the human genome in vitro. This represents another step towards gene-correction strategies for treating human disease.
This is a preview of subscription content, log in via an institution to check access.
References
Urnov, F. D. et al. Nature 435, 646–651 (2005).
Porteus, M. H. & Baltimore, D. Science 300, 763 (2003).
Bibikova, M. et al. Science 300, 764 (2003).
Kim, Y. G., Cha, J. & Chandrasegaran, S. Proc. Natl Acad. Sci. USA 93, 1156–1160 (1996).
Tupler, R. et al. Nature 409, 832–833 (2001).
Klug, A. FEBS Lett. 579, 892–894 (2005).
Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).
Hacein-Bey-Abina, S. et al. N. Engl. J. Med. 348, 255–256 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
High, K. The moving finger. Nature 435, 577–579 (2005). https://doi.org/10.1038/435577a
Published:
Issue Date:
DOI: https://doi.org/10.1038/435577a
- Springer Nature Limited
This article is cited by
-
Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells
Biotechnology Letters (2014)
-
Challenges with advanced therapy medicinal products and how to meet them
Nature Reviews Drug Discovery (2010)
-
Genetic medicines: treatment strategies for hereditary disorders
Nature Reviews Genetics (2006)